Thus, while PARP-1 inhibition may promote cell lethality through excessive DNA damage in cancer therapy, prudent PARP-1 suppression could offer a therapeutic avenue to regulate abnormal neuronal death in conditions such as Parkinson's disease (PD) and ischemia [56]. This evidence concerns the gene PARP1 and ischemia.